Intracutaneous Transplantation of Islets Within a Biodegradable Temporizing Matrix as an Alternative Site for Islet Transplantation.

Publication Year: 2023

DOI:
10.2337/db21-0841

PMCID:
PMC10202765

PMID:
36929171

Journal Information

Full Title: Diabetes

Abbreviation: Diabetes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Duality of Interest. P.T.C. and J.E.G. are stakeholders in Beta Cell Technology, a research and development company. J.E.G. is the inventor of the NovoSorb BTM and remains a shareholder in PolyNovo Biomaterials Pty. Ltd. (the manufacturers of NovoSorb BTM). No other potential conflicts of interest relevant to this article were reported."

Evidence found in paper:

"Funding. This work was supported by Juvenile Diabetes Research Foundation International (SRA-2016-257-S-B) and the Hospital Research Foundation, South Australia."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025